Neuland Laboratories Ltd
NSE:NEULANDLAB

Watchlist Manager
Neuland Laboratories Ltd Logo
Neuland Laboratories Ltd
NSE:NEULANDLAB
Watchlist
Price: 11 685.9004 INR -1.88%
Market Cap: 149.9B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

NEULANDLAB Price Targets Summary
Neuland Laboratories Ltd

Wall Street analysts forecast NEULANDLAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEULANDLAB is 17 697 INR with a low forecast of 14 847 INR and a high forecast of 21 000 INR.

NEULANDLAB Lowest Forecast
Wall Street Target
14 847 INR
27% Upside
NEULANDLAB Average Forecast
Wall Street Target
17 697 INR
51% Upside
NEULANDLAB Highest Forecast
Wall Street Target
21 000 INR
80% Upside
Lowest
Price Target
14 847 INR
27% Upside
Average
Price Target
17 697 INR
51% Upside
Highest
Price Target
21 000 INR
80% Upside
Neuland Laboratories Ltd Competitors:
Price Targets
326030
SK Biopharmaceuticals Co Ltd
37% Upside
ROG
Roche Holding AG
5% Upside
ARVN
Arvinas Inc
394% Upside
RX
Biosyent Inc
7% Upside
326030
SK Biopharmaceuticals Co Ltd
37% Upside
ROG
Roche Holding AG
5% Upside
ARVN
Arvinas Inc
394% Upside
RX
Biosyent Inc
7% Upside
TBPH
Theravance Biopharma Inc
58% Upside
4568
Daiichi Sankyo Co Ltd
70% Upside
G
GLENMARK
Glenmark Pharmaceuticals Ltd
16% Upside
GRANULES
Granules India Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Neuland Laboratories Ltd

For the last 8 years the compound annual growth rate for Neuland Laboratories Ltd's revenue is 15%. The projected CAGR for the next 3 years is 19%.

15%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Neuland Laboratories Ltd

For the last 8 years the compound annual growth rate for Neuland Laboratories Ltd's operating income is 27%. The projected CAGR for the next 3 years is 24%.

27%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Neuland Laboratories Ltd

For the last 8 years the compound annual growth rate for Neuland Laboratories Ltd's net income is 35%. The projected CAGR for the next 3 years is 26%.

35%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

See Also

Summary
NEULANDLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
NEULANDLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NEULANDLAB stock valuation using valuation multiples.
Wall Street Estimates
NEULANDLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NEULANDLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NEULANDLAB's stock price target?
Price Target
17 697 INR

According to Wall Street analysts, the average 1-year price target for NEULANDLAB is 17 697 INR with a low forecast of 14 847 INR and a high forecast of 21 000 INR.

What is Neuland Laboratories Ltd's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Neuland Laboratories Ltd's revenue is 15%. The projected CAGR for the next 3 years is 19%.

What is Neuland Laboratories Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Neuland Laboratories Ltd's operating income is 27%. The projected CAGR for the next 3 years is 24%.

What is Neuland Laboratories Ltd's Net Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Neuland Laboratories Ltd's net income is 35%. The projected CAGR for the next 3 years is 26%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.